Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Shares Outstanding (2022 - 2025)

Gossamer Bio (GOSS) has 2 years of Shares Outstanding data on record, last reported at $95.5 million in Q2 2023.

  • For Q2 2023, Shares Outstanding rose 24.39% year-over-year to $95.5 million; the TTM value through Jun 2023 reached $95.5 million, up 24.39%, while the annual FY2022 figure was $94.4 million, N/A changed from the prior year.
  • Shares Outstanding reached $95.5 million in Q2 2023 per GOSS's latest filing, roughly flat from $95.4 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $95.5 million in Q2 2023 and bottomed at $76.6 million in Q1 2022.